Kathleen Farrell

1.4k total citations
36 papers, 976 citations indexed

About

Kathleen Farrell is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Kathleen Farrell has authored 36 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in General Health Professions, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Psychiatry and Mental health. Recurrent topics in Kathleen Farrell's work include Epilepsy research and treatment (5 papers), Blood donation and transfusion practices (5 papers) and Cancer Treatment and Pharmacology (4 papers). Kathleen Farrell is often cited by papers focused on Epilepsy research and treatment (5 papers), Blood donation and transfusion practices (5 papers) and Cancer Treatment and Pharmacology (4 papers). Kathleen Farrell collaborates with scholars based in United States, United Kingdom and Australia. Kathleen Farrell's co-authors include Eamonn Ferguson, Claire Lawrence, Mona Newsome Wicks, V. James, K. C. Lowe, Richard Cronn, Aaron Liston, Roman Businský, John Syring and Fiona Patterson and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kathleen Farrell

33 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Farrell United States 15 208 168 124 117 108 36 976
Elizabeth Cummings Australia 21 253 1.2× 25 0.1× 659 5.3× 15 0.1× 207 1.9× 101 1.6k
Olav Muurlink Australia 17 86 0.4× 68 0.4× 177 1.4× 29 0.2× 148 1.4× 71 901
Heather Green Australia 23 209 1.0× 5 0.0× 96 0.8× 19 0.2× 116 1.1× 89 1.9k
Harry Levine United States 17 147 0.7× 6 0.0× 99 0.8× 148 1.3× 214 2.0× 48 1.2k
Kay Hogan Smith United States 10 43 0.2× 5 0.0× 128 1.0× 65 0.6× 28 0.3× 38 664
Henk ten Have United States 17 538 2.6× 10 0.1× 470 3.8× 23 0.2× 127 1.2× 91 1.1k
Bartira Ercí­lia Pinheiro da Costa Brazil 16 138 0.7× 5 0.0× 215 1.7× 18 0.2× 109 1.0× 79 1.3k
Devendra Raj Singh Nepal 20 126 0.6× 15 0.1× 253 2.0× 3 0.0× 142 1.3× 89 1.3k
Camilla Palmhøj Nielsen Denmark 21 293 1.4× 33 0.2× 523 4.2× 2 0.0× 115 1.1× 63 1.8k

Countries citing papers authored by Kathleen Farrell

Since Specialization
Citations

This map shows the geographic impact of Kathleen Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Farrell more than expected).

Fields of papers citing papers by Kathleen Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Farrell. The network helps show where Kathleen Farrell may publish in the future.

Co-authorship network of co-authors of Kathleen Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Farrell. A scholar is included among the top collaborators of Kathleen Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Farrell. Kathleen Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akram, Hammad, Avani C. Modi, Susan T. Herman, et al.. (2024). Barriers to Medication Adherence in People Living With Epilepsy. Neurology Clinical Practice. 15(1). e200403–e200403. 8 indexed citations
2.
Schultz, Rebecca, et al.. (2023). Project ECHO telementoring program in epilepsy for school nurses. Epilepsy & Behavior. 140. 109114–109114. 2 indexed citations
3.
Herman, Susan T., Kathleen Farrell, Nicholas S. Abend, et al.. (2021). Establishing a learning healthcare system to improve health outcomes for people with epilepsy. Epilepsy & Behavior. 117. 107805–107805. 29 indexed citations
4.
Farrell, Kathleen. (2015). Work-Life Balance Practices Among Irish Hotel Employees:Implications for HRM. Arrow - TU Dublin (Technological University Dublin). 12(2). 4. 1 indexed citations
5.
Farrell, Kathleen, et al.. (2015). Cardiovascular and type 2 diabetes risk factors in Liberian nurses. SHILAP Revista de lepidopterología. 4. 1–6. 4 indexed citations
6.
Hoerger, Thomas J., et al.. (2015). Can Incentives Improve Medicaid Patient Engagement and Prevent Chronic Diseases?. North Carolina Medical Journal. 76(3). 180–184. 9 indexed citations
8.
Ott, Patrick A., Ruth Oratz, Amanda C. Jones, et al.. (2009). Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma. Chemotherapy. 55(4). 221–227. 16 indexed citations
9.
Pavlick, Anna C., Jennifer Wu, John D. Roberts, et al.. (2009). Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors. Cancer Chemotherapy and Pharmacology. 64(4). 803–810. 20 indexed citations
10.
Liebes, Leonard, Franco M. Muggia, Anne C. Pavlick, et al.. (2006). Continuous intravenous infusion (CIVI) topotecan may be safely combined with tipifarnib. Journal of Clinical Oncology. 24(18_suppl). 2064–2064. 1 indexed citations
11.
Ferguson, Eamonn, Kathleen Farrell, V. James, & K. C. Lowe. (2004). Trustworthiness of information about blood donation and transfusion in relation to knowledge and perceptions of risk: an analysis of UK stakeholder groups. Transfusion Medicine. 14(3). 205–216. 21 indexed citations
12.
Fink, Michael, Anne C. Pavlick, Kathleen Farrell, et al.. (2004). A phase II trial of DTIC with thalidomide (thal) in metastatic melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7543–7543.
13.
Pavlick, Anne C., Michael Millward, Kathleen Farrell, et al.. (2004). A phase II study of epothilone B analog (EpoB)-BMS 247550 (NSC#710428) in stage IV malignant melanoma (MM). Journal of Clinical Oncology. 22(14_suppl). 7542–7542. 21 indexed citations
14.
Farrell, Kathleen, Eamonn Ferguson, V. James, & K. C. Lowe. (2002). Public perception of the risk of HIV infection associated with blood donation: the role of contextual cues. Transfusion. 42(6). 679–683. 17 indexed citations
15.
Ferguson, Eamonn, Kathleen Farrell, K. C. Lowe, & V. James. (2001). Perception of risk of blood transfusion: knowledge, group membership and perceived control. Transfusion Medicine. 11(2). 129–135. 23 indexed citations
16.
Farrell, Kathleen, Eamonn Ferguson, V. James, & K. C. Lowe. (2001). Confidence in the safety of blood for transfusion: the effect of message framing. Transfusion. 41(11). 1335–1340. 36 indexed citations
17.
Lowe, K. C., Kathleen Farrell, Eamonn Ferguson, & V. James. (2001). CURRENT PERCEIVED RISKS OF TRANSFUSION IN THE UK AND RELEVANCE TO THE FUTURE ACCEPTANCE OF BLOOD SUBSTITUTES. Artificial Cells Blood Substitutes and Biotechnology. 29(3). 179–189. 22 indexed citations
18.
Farrell, Kathleen. (1998). How could alternative therapies affect your practice?. PubMed. 97(6). 26–32. 1 indexed citations
19.
Farrell, Kathleen. (1994). Corporate Crime: Complex Criminal Trials The ASC Perspective. Current Issues in Criminal Justice. 5(3). 256–263. 1 indexed citations
20.
Farrell, Kathleen, et al.. (1979). Women physicians in medical academia. A national statistical survey.. PubMed. 241(26). 2808–12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026